Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.Pediatric Rheumatology.  16:71. 2018
2018 Aortitis With an Aneurysm at Initial Presentation of Crohn Disease.Journal of Pediatric Gastroenterology and Nutrition.  67:e12-e13. 2018
2018 Cardiovascular involvement at initial presentation of Crohn's Disease.Journal of Pediatric Gastroenterology and Nutrition2018
2018 Defining the normal appearance of the temporomandibular joints by magnetic resonance imaging with contrast: a comparative study of children with and without juvenile idiopathic arthritis.Pediatric Rheumatology.  16:8. 2018
2017 Evidence for Updating the Core Domain Set of Outcome Measures for Juvenile Idiopathic Arthritis: Report from a Special Interest Group at OMERACT 2016.Journal of Rheumatology.  44:1884-1888. 2017
2017 Risk of tuberculosis among Alabama children and adolescents treated with tumor necrosis factor inhibitors: a retrospective study.Pediatric Rheumatology.  15:79. 2017
2017 Changing Trends in Opioid Use Among Patients With Rheumatoid Arthritis in the United States.Arthritis and Rheumatology.  69:1733-1740. 2017
2016 The risk of hospitalized infection following initiation of biologic agents versus methotrexate in the treatment of juvenile idiopathic arthritis.Arthritis Research.  18:210. 2016
2016 Analysis of health care claims during the peri-transfer stage of transition from pediatric to adult care among juvenile idiopathic arthritis patients.Pediatric Rheumatology.  14:49. 2016
2016 Ustekinumab as a Therapeutic Option for Children With Refractory Enthesitis-Related Arthritis.JCR: Journal of Clinical Rheumatology.  22:282-284. 2016
2014 Recent trends in medication usage for the treatment of juvenile idiopathic arthritis and the influence of tumor necrosis factor inhibitors.Journal of Rheumatology.  41:2078-2084. 2014
2014 Risk of malignancy associated with biologic agents in pediatric rheumatic disease.Current Opinion in Rheumatology.  26:538-542. 2014
2013 Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis.Arthritis and Rheumatism.  65:1384-1389. 2013
2013 What is the background incidence of malignancy in children with rheumatic disease?Current Rheumatology Reports.  15:310. 2013
2012 Intensive care requirement, rather than degree of serum ferritin elevation, predicts mortality in macrophage activation syndrome.Pediatric Critical Care Medicine.  13:616. 2012
2012 Sarcoidosis in a young child with Alagille syndrome: a case report.Pediatric Rheumatology.  10:32. 2012
2011 Brain cavernomas associated with en coup de sabre linear scleroderma: Two case reports.Pediatric Rheumatology.  9:18. 2011
2011 Anakinra as first-line disease-modifying therapy in systemic juvenile idiopathic arthritis: report of forty-six patients from an international multicenter series.Arthritis and Rheumatism.  63:545-555. 2011
2011 Successful treatment of pediatric IgG4 related systemic disease with mycophenolate mofetil: case report and a review of the pediatric autoimmune pancreatitis literature.Pediatric Rheumatology.  9:1. 2011

Chapter

Year Title Altmetric
2018 Diskitis.  302-303. 2018
2018 Spondyloarthropathy.  872-873. 2018

Research Overview

  • My primary research interests are in epidemiologic analysis related to juvenile idiopathic arthritis (JIA). Specifically I am interested in the use of medications to treat JIA, the outcomes of JIA in adulthood, and the comparative effectiveness of treatment modalities.
  • Full Name

  • Melissa Mannion